PTC Therapeutics PTCT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's retained earnings?
- PTC Therapeutics (PTCT) reported retained earnings of -$2.97B in Q1 2026.
- How has PTC Therapeutics's retained earnings changed year-over-year?
- PTC Therapeutics's retained earnings decreased by 6.7% year-over-year, from -$2.78B to -$2.97B.
- What is the long-term trend for PTC Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), PTC Therapeutics's retained earnings has grown at a 12.7% compound annual growth rate (CAGR), from -$1.63B to -$2.96B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.